Insiders / Gemayel Georges / Activity
Activity — Gemayel Georges
11 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Sell | SUPN Supernus Pharmaceuticals Inc Common Stock | $537.1K | -10K -26.21% | 28,159 0.05% of shares | medium |
| Mar 6, 2026 | Sell | SUPN Supernus Pharmaceuticals Inc Common Stock | $465.7K | -9K -24.37% | 27,277 0.05% of shares | medium |
| Mar 6, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Common Stock | $200.0K | +8K +28.07% | 36,064 0.06% of shares | low |
| Feb 23, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Common Stock | $194.7K | +15K +80.28% | 33,684 0.06% of shares | low |
| Feb 24, 2026 | Grant | SUPN Supernus Pharmaceuticals Inc Common Stock | $0 | +4K +13.29% | 38,159 0.07% of shares | low |
| Jun 18, 2026 | Grant | IRON Disc Medicine, Inc. Stock Option (Right to Buy) | — | +6K | 6,212 0.02% of shares | low |
| Mar 6, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Director Stock Option (Right to Buy) | — | -8K -100.00% | 0 0.00% of shares | low |
| Feb 24, 2026 | Other | SUPN Supernus Pharmaceuticals Inc Restricted Stock Unit | — | -4K -100.00% | 0 0.00% of shares | low |
| Feb 23, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Director Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |
| Feb 18, 2026 | Grant | SUPN Supernus Pharmaceuticals Inc Director Stock Option (Right to Buy) | — | +5K | 4,977 <0.01% of shares | low |
| Feb 18, 2026 | Grant | SUPN Supernus Pharmaceuticals Inc Restricted Stock Unit | — | +3K | 2,989 <0.01% of shares | low |